All News
Seropositivity Linked to Bronchiectasis in Rheumatoid Arthritis
Rheumatoid arthritis associated bronchiectasis (RA-BR) is uncommon, and is unrelated to interstitial lung disease (ILD), but like ILD, can substantially impact RA outcomes.
Read Article
Environmental Pollutants Ups Autoimmune Disease Risk
An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, connective tissue diseases (CTDs) and inflammatory bowel diseases (IBD).
Read Article
Low Dose IL-2 Efficacy in Rheumatoid Arthritis
A novel biologic intervention trial has shown that subcutaneous, intermittent therapy with low-dose interleukin-2 (Ld-IL2) is potentially effective and safe in rheumatoid arthritis (RA).
Read Article
@Janetbirdope on drug cycling in #RA. What’s beyond TNFi failure? No golden rule, but:
👉🏻 switching to non-TNF can be superior than staying with the TNFi class
👉🏻 response to other bDMARs maybe blunted in non-TNFi naive
👉🏻 JAKi can be a good choice for some @RheumNow #RNL2022 https://t.co/25MiiFh2CK
Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
How NOT to get rheumatoid arthritis. Excellent tips by @karen_kc123 #RNL2022 #rheumatoidarthritis https://t.co/brLeWzioQD
Jonathan Hausmann MD hausmannMD ( View Tweet)
Patients often ask me what they can do on their part to help their disease... this is it! @karen_kc123 reviews the modifable risks in RA. @rheumnow #RNL2022 @CreakyJoints https://t.co/FM0BtNX6eb
TheDaoIndex KDAO2011 ( View Tweet)
#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR
Janet Pope Janetbirdope ( View Tweet)
Dr. Elena Myasoedova on Multimorbidities and RA
Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts
@RheumNow #RNL2022 https://t.co/N6VPdU6wzV
Robert B Chao, MD doctorRBC ( View Tweet)
Cool idea 💡 for #treatment of #multimorbidity in #rheumatoid arthritis from an interactive web platform #RNL2022 @RheumNow https://t.co/QlTWCV8s9F
Janet Pope Janetbirdope ( View Tweet)
Role of cytokines in pain ?!
Notice CNS activity disappeared immediately before TJC/SJC improvement!!
@Tuhina_Neogi @RheumNow #RNL2022 https://t.co/TXKZwepBTF
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
@Janetbirdope on drug cycling vs. switching in RA
Interesting data showing switching to non-TNFi superior to cycling in TNFi-incomplete responders
Most bDMARDs and JAKi have blunted response post-TNFi
@RheumNow #RNL2022 https://t.co/Lb3wvHZdzN
Robert B Chao, MD doctorRBC ( View Tweet)
@Janetbirdope shares her study on real world retention of JAKi vs biologics in #RA #RNL2022 @rheumnow https://t.co/hNxQ8t4LHH
TheDaoIndex KDAO2011 ( View Tweet)
#ClinicalPearl #multimorbidity worsens outcomes in #rheumatoid arthritis. 50% of #RA pts has this and 2x > than age sex matched pop’n. Worse as interplay of diseases, drug disposition, med adherence, drug interactions, etc #RNL2022 @RheumNow Elena Myasoedova https://t.co/aTF0O8o0tg
Janet Pope Janetbirdope ( View Tweet)
Dr. Elena Myasoedova defines multimorbidity and its difference for comorbidities. Multimorbidity (MM) focuses on the patient, comorbidities focuses on the disease. RA pts have 2.3 X higher MM and can precede RA. #RNL2022 @rheumnow https://t.co/FE489rJnnP
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Philip Mease on the importance of recognizing fibromyalgia, especially concurrently with rheumatic diseases
FM does impact disease severity, esp in RA and AS
@RheumNow #RNL2022 https://t.co/cGFYYdf6GU
Robert B Chao, MD doctorRBC ( View Tweet)
Dr. Jonathan Hausman on JIA
Most subjects equivalent to adult forms of inflammatory arthritis - note early onset seronegative oligoarthritis
Tips on transitioning to adult care - determine extent of active disease vs. chronic damage
@RheumNow #RNL2022 https://t.co/MhjH04PQ3e
Robert B Chao, MD doctorRBC ( View Tweet)
Transition programs improve health and QoL of pedi-to-adult rheumatology patients in addition to their autonomy/independence! Dr. @hausmannMD gives both pediatric and adult recommendations to ease care at #RNL2022 @RheumNow https://t.co/e5erQ5nkcE
Dr. Rachel Tate uptoTate ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
If you don’t treat active #rheumatoidarthritis while woman 👩 is pregnant, you may do more harm to 👶🏻. Look at the data @UmaMahadevanIBD #RNL2022 @RheumNow https://t.co/6P94IdfS15
Janet Pope Janetbirdope ( View Tweet)
Korean study (TB endemic area) shows the risk of mTB & nontuberculous mycobact infx (NTM) are equal and nearly doubled in RA pts on TNFi. Among 4356 RA (1089 on TNFi) NTM & TB rates were 328- and 341/100K PY (US rate is 6/100K PY) https://t.co/QwzTYt3wX4 https://t.co/GLWreoQ6ih
Dr. John Cush RheumNow ( View Tweet)
